Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the benefit of oral panobinostat monotherapy given to
women with HER2-negative locally recurrent or metastatic breast cancer.